Standard Biotools | FLDM - Selling And Administration Expenses


Standard Biotools reported $18.61M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Illumina USD 273M 1000K Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Nikon Corporation JPY 66.83B 10.27B Jun/2026
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Revvity USD 278.58M 24.69M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sony JPY 568.37B 78.85B Jun/2026
Standard Biotools USD 18.61M 2.94M Mar/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Waters USD 405M 11M Jun/2026